Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
BX1000 · 1 trial · 3 indications
Assessment of Intubation Conditions (Poor, Good, Excellent) Following Administration of Neuromuscular Blocking agent
| Arm | Type | Description |
|---|---|---|
| BX1000 0.15 mg/kg | EXPERIMENTAL | BX1000 0.15 mg/kg IV Bolus |
| BX1000 0.25 mg/kg | EXPERIMENTAL | BX1000 0.25 mg/kg IV Bolus |
| BX1000 0.35 mg/kg | EXPERIMENTAL | BX1000 0.35 mg/kg IV Bolus |
| Rocuronium 0.6 mg/kg | ACTIVE_COMPARATOR | Rocuronium bromide 0.6 mg/kg IV Bolus |
| Name | Type | Description |
|---|---|---|
| BX1000 | DRUG | IV BX1000 |
| Rocuronium Bromide | DRUG | IV Rocuronium |
Inclusion Criteria: * Providing informed consent * Undergoing elective surgery utilizing IV general anesthesia * Normal airway assessment Exclusion Criteria: * Unstable disease or emergency surgical conditions * Known hypersensitivity to rocuronium, other NMB or study medications * History of ana...